LCN2 has been reported to play a key role in the development and progression of several tumors, such as breast cancer [28], thyroid cancer, CRC, non-small-cell lung cancer, hepatocellular carcinoma, and leukemia [27, 29]. Here, LCN2 is linked to hepatocellular carcinoma.